首发精神分裂症患者抗精神病药物治疗的依从性、复发及再次住院情况
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia.
作者信息
Morken Gunnar, Widen Jan H, Grawe Rolf W
机构信息
Department of Neuroscience, Faculty of Medicine, NTNU, N-7006 Trondheim, Norway.
出版信息
BMC Psychiatry. 2008 Apr 30;8:32. doi: 10.1186/1471-244X-8-32.
Abstract
BACKGROUND
The aims of this study were to describe outcome with respect to persistent psychotic symptoms, relapse of positive symptoms, hospital admissions, and application of treatment by coercion among patients with recent onset schizophrenia being adherent and non-adherent to anti-psychotic medication.
MATERIALS AND METHODS
The study included 50 patients with recent onset schizophrenia, schizoaffective or schizophreniform disorders. The patients were clinically stable at study entry and had less than 2 years duration of psychotic symptoms. Good adherence to antipsychotic medication was defined as less than one month without medication. Outcomes for poor and good adherence were compared over a 24-month follow-up period.
RESULTS
The Odds Ratio (OR) of having a psychotic relapse was 10.27 and the OR of being admitted to hospital was 4.00 among non-adherent patients. Use of depot-antipsychotics were associated with relapses (OR = 6.44).
CONCLUSION
Non-adherence was associated with relapse, hospital admission and having persistent psychotic symptoms. Interventions to increase adherence are needed.
TRIAL REGISTRATION
Current Controlled Trials NCT00184509. Key words: Adherence, schizophrenia, antipsychotic medication, admittances, relapse.
摘要
背景
本研究旨在描述近期发病的精神分裂症患者中，坚持和不坚持使用抗精神病药物的患者在持续性精神病症状、阳性症状复发、住院情况以及强制治疗应用方面的结果。
材料与方法
该研究纳入了50例近期发病的精神分裂症、精神分裂症样情感障碍或精神分裂症样障碍患者。患者在研究开始时临床稳定，精神病症状持续时间少于2年。对抗精神病药物的良好依从性定义为停药时间少于1个月。在24个月的随访期内比较了依从性差和依从性好的患者的结果。
结果
在不依从的患者中，精神病复发的优势比（OR）为10.27，住院的OR为4.00。使用长效抗精神病药物与复发相关（OR = 6.44）。
结论
不依从与复发、住院以及持续性精神病症状有关。需要采取干预措施来提高依从性。
试验注册
当前对照试验NCT00184509。关键词：依从性、精神分裂症、抗精神病药物、住院、复发。
相似文献
1
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia.首发精神分裂症患者抗精神病药物治疗的依从性、复发及再次住院情况
BMC Psychiatry. 2008 Apr 30;8:32. doi: 10.1186/1471-244X-8-32.
2
Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia.综合治疗对近期发病精神分裂症随机试验中抗精神病药物依从性的影响。
J Clin Psychiatry. 2007 Apr;68(4):566-71. doi: 10.4088/jcp.v68n0409.
3
Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.对抗精神病药物的态度：临床变量的影响以及与医疗专业人员的关系
Arch Gen Psychiatry. 2005 Jul;62(7):717-24. doi: 10.1001/archpsyc.62.7.717.
4
Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.棕榈酸帕利哌酮单月制剂对精神分裂症患者复发预防的影响：一项为期一年、开放性研究的事后分析，按药物依从性分层。
J Psychopharmacol. 2018 Jun;32(6):691-701. doi: 10.1177/0269881118772449. Epub 2018 May 16.
5
TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.抗精神病药物在新诊断的精神分裂症或持续性妄想障碍且精神病症状缓解患者中的减量停药与维持治疗对比研究：一项随机临床试验的研究方案
Trials. 2017 Sep 29;18(1):445. doi: 10.1186/s13063-017-2172-4.
6
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.首次精神病发作康复期患者抗精神病药物依从性的预测因素
Schizophr Res. 2006 Mar;83(1):53-63. doi: 10.1016/j.schres.2005.10.016. Epub 2006 Mar 9.
7
Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).针对未坚持服用抗精神病维持药物的患者，采用经济激励措施提高其依从性的一项整群随机对照试验（FIAT）。
BMC Psychiatry. 2009 Sep 28;9:61. doi: 10.1186/1471-244X-9-61.
8
[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].[使用长效注射用利培酮的基本原理：法国精神科医生的一项调查]
Encephale. 2013 May;39 Suppl 1:S8-14. doi: 10.1016/j.encep.2012.03.005. Epub 2013 Mar 28.
9
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析：长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
10
Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion.非自愿住院对药物依从性、治疗参与度和对强制治疗的认知的长期影响。
Soc Psychiatry Psychiatr Epidemiol. 2013 Nov;48(11):1787-96. doi: 10.1007/s00127-013-0687-x. Epub 2013 Apr 19.
引用本文的文献
1
Financial incentives and long-acting injectable antipsychotics engagement: community mental health professionals' perspectives.经济激励措施与长效注射用抗精神病药物的使用：社区精神卫生专业人员的观点
BMC Psychiatry. 2025 Aug 18;25(1):791. doi: 10.1186/s12888-025-07165-9.
2
Real-World Prescribing Patterns of Long-Acting Injectable Antipsychotics in Australian Psychiatric Inpatients: Trends, Clinical Outcomes, and Substance Use Prevalence.澳大利亚精神科住院患者长效注射用抗精神病药物的真实世界处方模式：趋势、临床结局及物质使用患病率
Drugs Real World Outcomes. 2025 Aug 6. doi: 10.1007/s40801-025-00511-z.
3
Machine Learning and Interpretability Study for Predicting 30-Day Unplanned Readmission Risk of Schizophrenia: A Retrospective Study.用于预测精神分裂症30天非计划再入院风险的机器学习与可解释性研究：一项回顾性研究
Neuropsychiatr Dis Treat. 2025 Jul 28;21:1509-1521. doi: 10.2147/NDT.S522675. eCollection 2025.
4
Motivational Interviewing in Patients with Acute Psychosis: A Feasibility Study.急性精神病患者的动机性访谈：一项可行性研究。
Schizophr Bull Open. 2025 Feb 8;6(1):sgaf004. doi: 10.1093/schizbullopen/sgaf004. eCollection 2025 Jan.
5
Physician Experiences With and Perspectives on Clozapine Prescribing.医生使用氯氮平处方的经验与观点。
JAMA Netw Open. 2025 Feb 3;8(2):e2459311. doi: 10.1001/jamanetworkopen.2024.59311.
6
Treatment with medication for patients with psychosis within 2 days during waiting in the accident and emergency department and its correlation with length of in-patient stay: retrospective database study.急诊部候诊期间2天内对精神病患者进行药物治疗及其与住院时间的相关性：回顾性数据库研究
BJPsych Open. 2024 Nov 11;10(6):e206. doi: 10.1192/bjo.2024.804.
7
Relapse rate and predictors among people with severe mental illnesses at Debre Markos Comprehensive specialized hospital, Northwest Ethiopia: a prospective follow up study.埃塞俄比亚西北部德布雷马尔科斯综合专科医院重度精神疾病患者的复发率及预测因素：一项前瞻性随访研究
Eur Arch Psychiatry Clin Neurosci. 2024 Sep 18. doi: 10.1007/s00406-024-01900-1.
8
Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia.抗精神病药治疗精神分裂症的疗效和不良反应在女性和男性个体之间的性别差异。
CNS Drugs. 2024 Jul;38(7):559-570. doi: 10.1007/s40263-024-01089-w. Epub 2024 May 7.
9
Clinical Experience on the Use of a Single-day, Two-injection Start Initiation Regimen of Aripiprazole Once Monthly in Patients With Schizophrenia in Spain: SaTISfy Study.西班牙一项为期 1 天、2 针起始的阿立哌唑每月 1 次给药方案治疗精神分裂症患者的临床经验：SaTISfy 研究。
J Psychiatr Pract. 2024 Mar 1;30(2):82-94. doi: 10.1097/PRA.0000000000000776.
10
[Association Between Medication Compliance and Various Risky Behaviors in Patients With Schizophrenia].[精神分裂症患者的药物依从性与各种危险行为之间的关联]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1201-1207. doi: 10.12182/20231360303.
本文引用的文献
1
Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia.综合治疗对近期发病精神分裂症随机试验中抗精神病药物依从性的影响。
J Clin Psychiatry. 2007 Apr;68(4):566-71. doi: 10.4088/jcp.v68n0409.
2
Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study.近期发病精神分裂症的两年持续早期治疗：一项随机对照研究。
Acta Psychiatr Scand. 2006 Nov;114(5):328-36. doi: 10.1111/j.1600-0447.2006.00799.x.
3
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.抗精神病药物对慢性精神分裂症患者的疗效。
N Engl J Med. 2005 Sep 22;353(12):1209-23. doi: 10.1056/NEJMoa051688. Epub 2005 Sep 19.
4
Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.精神分裂症医疗补助受益人群中抗精神病药物治疗的依从性与医疗保健成本
Am J Psychiatry. 2004 Apr;161(4):692-9. doi: 10.1176/appi.ajp.161.4.692.
5
Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.药房数据显示，精神分裂症患者依从性差会增加住院风险。
Med Care. 2002 Aug;40(8):630-9. doi: 10.1097/00005650-200208000-00002.
6
Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale.近期起病的精神分裂症和躁狂症的症状维度：24项简明精神病评定量表的主成分分析
Psychiatry Res. 2000 Dec 27;97(2-3):129-35. doi: 10.1016/s0165-1781(00)00228-6.
7
Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia.精神药理学：精神分裂症患者的洞察力、共病物质滥用与药物依从性
Psychiatr Serv. 2001 Feb;52(2):161-3, 166. doi: 10.1176/appi.ps.52.2.161.
8
Optimal treatment for psychosis in an international multisite demonstration project. Optimal Treatment Project Collaborators.
Psychiatr Serv. 1999 May;50(5):615-8. doi: 10.1176/ps.50.5.615.
9
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.首发精神分裂症或分裂情感性障碍缓解后复发的预测因素。
Arch Gen Psychiatry. 1999 Mar;56(3):241-7. doi: 10.1001/archpsyc.56.3.241.
10
Factors influencing relapse in the long-term course of schizophrenia.精神分裂症长期病程中影响复发的因素。
Schizophr Res. 1997 Dec 19;28(2-3):199-206. doi: 10.1016/s0920-9964(97)00131-x.
Zotero 插件